PYC.LSE Physiomics Plc

Healthcare Biotechnology London Exchange
0.0042 GBX
Close of Nov 3, 2026
0.2525 0.8000
Market cap
GBX 1.93M
P/E
-
P/B
3.68x
ROE
-133.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is PYC.LSE undervalued?

Graham number

The Graham number of Physiomics Plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Physiomics Plc fundamental analysis

No fundamental analysis for Physiomics Plc yet.

Physiomics Plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Physiomics Plc

Physiomics Plc engages in the provision of consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the f…

Full company profile